Gossamer Bio (GOSS) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The absence of commercial sales and a reliance on grants create high risks, as confirmed by the EV/EBITDA trajectory of Gossamer Bio, Inc. (GOSS). The value of 0.00 represents the current level of this metric. The business relies on an asset-light model with R&D based in the US, outsourcing drug manufacturing to contractors. All clinical trials have been fully delegated to external partners, which minimizes the internal costs of Gossamer Bio, Inc. (GOSS).
gossamerbio.com - analytical breakdowns and key metrics (GOSS)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
GOSS - Net Financial Result|Expected Profit Gossamer Bio, Inc.|GOSS - Business Payback Period|Forward P/E Multiple Gossamer Bio, Inc.|GOSS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gossamer Bio Corp.|GOSS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Gossamer Bio|GOSS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months gossamerbio.com|GOSS - Earnings per share increase in current year|Expected earnings per share growth for next year Gossamer Bio, Inc.
Initial company analysis:Gossamer Corp GOSS
The EV/EBITDA multiple compares the total enterprise value, including debt, with operating profit before taxes and depreciation, allowing for an assessment of the asset's real value regardless of the financing structure. By analyzing the EV/EBITDA valuation multiple for capital-intensive businesses, an investor can identify whether shares of Gossamer Bio, Inc. (GOSS) are overvalued, given that its pulmonary hypertension developments are protected by humanitarian status and stable global supplies.
Main competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Dianthus Corp (DNTH)|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Precigen Inc (PGEN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Total Company Value to Operating Income Before Depreciation Ratio Nektar Corp|EV/EBITDA Multiple UPB (Upstream Bio Inc)|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KalVista Pharma (KALV) - Enterprise Value to EBITDA Ratio|SEPN: EV/EBITDA Multiple|Company Value to EBITDA Pieris Corp (PVLA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Savara Inc.|RIGL: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|rapt.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Aerovate - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Tiziana Life Sciences Ltd. (TLSA)|Enterprise Value to EBITDA Ratio CABA|VTYX: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple THTX|Total Company Value to Operating Income Before Depreciation Ratio avalotx.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|AGEN: Enterprise Value to Operating Income Before Depreciation|Climb Bio, Inc. - EV/EBITDA Multiple|zurabio.com (ZURA) - Enterprise Value to EBITDA Ratio|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|ADAG - Total Company Value to Operating Income Before Depreciation Ratio|IMA (ImageneBio) - EV/EBITDA Multiple|STTK - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|Total Company Value to Operating Income Before Depreciation Ratio Atara Biotherapeutics, Inc. (ATRA)|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio X4 Pharmaceuticals Inc. XFOR|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CELU (Celularity)|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|Business Value to Operating Income Before Depreciation ENLV|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA: EV/EBITDA Multiple|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio CARM|XTLB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BOLT|Total Company Value to Operating Income Before Depreciation Ratio hcwbiologics.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM - Enterprise Value to EBITDA Ratio|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|EV/EBITDA Multiple SCNI|CALI - Company Value to EBITDA|EV/EBITDA Multiple AFMD (Affimed N.V.)|Enterprise Value to EBITDA Multiple Allakos Inc|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA IGM Biosciences, Inc.|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|OCEA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
